Dr. Benjamin Cameron, DO

NPI: 1205248424
Total Payments
$2,189
2024 Payments
$752.68
Companies
29
Transactions
136
Medicare Patients
4,423
Medicare Billing
$403,030

Payment Breakdown by Category

Food & Beverage$2,189 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,189 136 100.0%

Top Paying Companies

Company Total Records Latest Year
Lilly USA, LLC $263.68 19 $0 (2024)
Novo Nordisk Inc $253.26 16 $0 (2024)
PFIZER INC. $228.20 16 $0 (2024)
GlaxoSmithKline, LLC. $189.55 12 $0 (2024)
Biohaven Pharmaceutical Holding Company Ltd. $145.16 3 $0 (2022)
Boehringer Ingelheim Pharmaceuticals, Inc. $139.61 8 $0 (2024)
AstraZeneca Pharmaceuticals LP $138.68 9 $0 (2024)
Kowa Pharmaceuticals America, Inc. $113.63 7 $0 (2023)
IDORSIA PHARMACEUTICALS US INC $83.99 4 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $78.45 5 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $752.68 44 Novo Nordisk Inc ($169.74)
2023 $607.32 40 Lilly USA, LLC ($133.28)
2022 $262.76 10 Biohaven Pharmaceutical Holding Company Ltd. ($145.16)
2020 $11.96 1 Merck Sharp & Dohme Corporation ($11.96)
2019 $128.92 10 PFIZER INC. ($35.32)
2017 $425.18 31 PFIZER INC. ($64.09)

All Payment Transactions

136 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/26/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.19 General
Category: RESPIRATORY
11/13/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $14.66 General
Category: RESPIRATORY
11/06/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $26.17 General
11/04/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $17.82 General
Category: Diabetes
10/23/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $19.97 General
Category: Diabetes
10/10/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $13.61 General
Category: DIABETES
10/09/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $16.61 General
Category: Obesity
10/01/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.17 General
Category: Cardiovascular and Metabolism
09/26/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $17.26 General
Category: Diabetes
09/09/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.40 General
Category: RESPIRATORY
09/04/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $20.82 General
Category: Diabetes
08/21/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $20.03 General
Category: Respiratory
08/13/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $15.52 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/09/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $13.10 General
Category: Obesity
08/07/2024 Xeris Pharmaceuticals, Inc. GVOKE HYPOPEN (Drug) Food and Beverage In-kind items and services $20.03 General
Category: Diabetes
08/05/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $16.41 General
Category: Diabetes
08/01/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $20.14 General
Category: RESPIRATORY
07/31/2024 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $16.96 General
Category: Bone Health
07/25/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $12.51 General
Category: Diabetes
07/24/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $16.54 General
Category: Obesity
07/22/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $13.12 General
Category: Cardiovascular and Metabolism
07/09/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $21.01 General
Category: Diabetes
06/27/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $15.25 General
Category: Respiratory
06/13/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.22 General
Category: Cardiovascular and Metabolism
05/23/2024 PFIZER INC. NURTEC ODT (Drug) Food and Beverage In-kind items and services $23.24 General
Category: PAIN

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 28 1,781 2,455 $454,499 $135,906
2022 16 941 1,352 $345,909 $107,647
2021 10 769 1,022 $235,085 $77,502
2020 11 932 1,305 $275,212 $81,974
Total Patients
4,423
Total Services
6,134
Medicare Billing
$403,030
Procedure Codes
65

All Medicare Procedures & Services

65 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 278 455 $142,624 $36,783 25.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 270 270 $86,505 $34,147 39.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 115 135 $59,566 $16,436 27.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 163 192 $42,553 $11,878 27.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 95 95 $38,691 $11,287 29.2%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 19 19 $7,781 $3,080 39.6%
G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a Office 2023 35 92 $9,164 $2,606 28.4%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 30 30 $3,481 $2,274 65.3%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 13 13 $5,324 $2,103 39.5%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 112 112 $5,040 $2,016 40.0%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 202 211 $7,326 $1,946 26.6%
20610 Aspiration and/or injection of fluid from large joint Office 2023 28 38 $5,999 $1,886 31.4%
G0008 Administration of influenza virus vaccine Office 2023 50 50 $2,000 $1,476 73.8%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2023 37 38 $4,905 $1,398 28.5%
99497 Advance care planning, first 30 minutes Office 2023 19 19 $3,927 $1,393 35.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 17 17 $4,634 $1,353 29.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 23 23 $3,165 $886.72 28.0%
80305 Testing for presence of drug, read by direct observation Office 2023 45 46 $1,610 $568.10 35.3%
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or Office 2023 13 23 $1,842 $553.64 30.1%
96372 Injection of drug or substance under skin or into muscle Office 2023 37 48 $1,682 $473.86 28.2%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2023 13 13 $1,470 $450.06 30.6%
90688 Influenza vaccine, quadrivalent, 0.5 ml dosage Office 2023 14 14 $716.40 $286.44 40.0%
96127 Assessment of emotional or behavioral problems Office 2023 34 61 $686.25 $210.04 30.6%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 39 203 $4,760 $161.92 3.4%
36415 Insertion of needle into vein for collection of blood sample Office 2023 11 11 $236.50 $92.40 39.1%

About Dr. Benjamin Cameron, DO

Dr. Benjamin Cameron, DO is a Internal Medicine healthcare provider based in Longview, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2014. The National Provider Identifier (NPI) number assigned to this provider is 1205248424.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Cameron, DO has received a total of $2,189 in payments from pharmaceutical and medical device companies, with $752.68 received in 2024. These payments were reported across 136 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,189).

As a Medicare-enrolled provider, Cameron has provided services to 4,423 Medicare beneficiaries, totaling 6,134 services with total Medicare billing of $403,030. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Internal Medicine
  • Location Longview, TX
  • Active Since 05/22/2014
  • Last Updated 12/08/2021
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1205248424

Products in Payments

  • NURTEC ODT (Drug) $214.56
  • JARDIANCE (Drug) $182.67
  • Rybelsus (Drug) $119.41
  • TRELEGY ELLIPTA (Drug) $111.13
  • SEGLENTIS (Drug) $91.92
  • QUVIVIQ (Drug) $83.99
  • Kerendia (Drug) $78.45
  • ELIQUIS (Drug) $72.19
  • Wegovy (Drug) $64.46
  • TRULICITY (Drug) $61.91
  • FARXIGA (Drug) $58.11
  • JANUVIA (Drug) $50.25
  • FORTEO (Drug) $45.89
  • Ozempic (Drug) $41.84
  • QULIPTA (Drug) $38.92
  • UBRELVY (Drug) $36.55
  • CHANTIX (Drug) $35.32
  • EVENITY (Biological) $34.93
  • BEVESPI AEROSPHERE (Drug) $34.04
  • MOUNJARO (Drug) $33.84

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Longview